Back to search

Variations in the 5-Hydroxytryptamine Type 3B Receptor Gene as Predictors of the Efficacy of Antiemetic Treatment in Cancer Patients

Data up to Jan 2025

Published2003
Citations157
References25

Total Citations Per Year

Abstract

References (25)

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.

1997 • 995 citations

Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel

1991 • 976 citations

Molecular biology of 5-HT receptors

1994 • 679 citations

Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines

1999 • 678 citations

Proposal for classifying the acute emetogenicity of cancer chemotherapy.

1997 • 619 citations

The 5-HT3B subunit is a major determinant of serotonin-receptor function

1999 • 555 citations

The Area Postrema and Vomiting

1994 • 337 citations

The Pharmacological and Functional Characteristics of the Serotonin 5-HT3A Receptor Are Specifically Modified by a 5-HT3B Receptor Subunit

1999 • 278 citations

5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting

1998 • 268 citations

Patient-Tailored Antiemetic Treatment With 5-Hydroxytryptamine Type 3 Receptor Antagonists According to Cytochrome P-450 2D6 Genotypes

2002 • 254 citations

PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST

1987 • 193 citations

The 5-HT3 Receptor Channel

1995 • 180 citations

Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species.

1995 • 179 citations

Defining the Emetogenicity of Cancer Chemotherapy Regimens: Relevance to Clinical Practice

1999 • 145 citations

Ultrastructure of the 5‐Hydroxytryptamine3 Receptor

1995 • 132 citations

Cloning and functional expression of a human 5-hydroxytryptamine type 3AS receptor subunit.

1995 • 117 citations

Double-blind, dose-finding study of four intravenous doses of dexamethasone in the prevention of cisplatin-induced acute emesis. Italian Group for Antiemetic Research.

1998 • 95 citations

Mechanism of the Anti-Emetic Activity of 5-HT<sub>3</sub> Receptor Antagonists

1992 • 90 citations

An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting

1997 • 83 citations

Desperately seeking subunits: are native 5-HT3 receptors really homomeric complexes?

1998 • 65 citations

Cancer therapy, vomiting, and antiemetics

1990 • 61 citations

Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms

2000 • 60 citations

The Effectiveness of a Single Intravenous Dose of Ondansetron

1992 • 20 citations

Molecular Cloning of Alternatively Spliced Human 5‐HT3 Receptor cDNAsa

1998 • 17 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Variations in the 5-Hydroxytryptamine Type 3B Receptor Gene as Predictors of the Efficacy… (2003) – Journal of Clinical Oncology | Metascience Observatory Explorer